Response to letter to the Editors—Safety of long-term denosumab therapy

Alison T. Stopeck; Douglas J. Warner

doi:10.1007/s00520-016-3492-8

Response to letter to the Editors—Safety of long-term denosumab therapy

Alison T. Stopeck
, Douglas J. Warner

Medical Oncology

Amgen Incorporated

Research output: Contribution to journal › Letter › peer-review

15 Scopus citations

Original language	English
Pages (from-to)	353-355
Number of pages	3
Journal	Supportive Care in Cancer
Volume	25
Issue number	2
DOIs	https://doi.org/10.1007/s00520-016-3492-8
State	Published - Feb 1 2017

Access to Document

10.1007/s00520-016-3492-8

Cite this

@article{95b86f28b6ee4544b999f2c996b3eac0,

title = "Response to letter to the Editors—Safety of long-term denosumab therapy",

author = "Stopeck, \{Alison T.\} and Warner, \{Douglas J.\}",

year = "2017",

month = feb,

day = "1",

doi = "10.1007/s00520-016-3492-8",

language = "English",

volume = "25",

pages = "353--355",

journal = "Supportive Care in Cancer",

issn = "0941-4355",

number = "2",

}

TY - JOUR

T1 - Response to letter to the Editors—Safety of long-term denosumab therapy

AU - Stopeck, Alison T.

AU - Warner, Douglas J.

PY - 2017/2/1

Y1 - 2017/2/1

UR - https://www.scopus.com/pages/publications/84996844647

U2 - 10.1007/s00520-016-3492-8

DO - 10.1007/s00520-016-3492-8

M3 - Letter

C2 - 27885467

AN - SCOPUS:84996844647

SN - 0941-4355

VL - 25

SP - 353

EP - 355

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

IS - 2

ER -

Response to letter to the Editors—Safety of long-term denosumab therapy

Access to Document

Other files and links

Fingerprint

Cite this